China Pharma Holdings (CPHI) Acquires Captopril Microcapsule Patent for $6.3 Million
China Pharma Holdings (CPHI) acquired a Captopril microcapsule patent for $6.3 million and will issue 3.5 million restricted shares.
8-K
Moleculin Biotech (MBRX) Secures $6.8 Million Through Warrant Inducement Offer
Moleculin Biotech (MBRX) entered into warrant exercise inducement offers, generating $6.8 million in gross proceeds.
MAIA Biotechnology (MAIA) Receives FDA Fast Track Designation for Ateganosine in NSCLC
MAIA Biotechnology (MAIA) received FDA Fast Track Designation for ateganosine in NSCLC patients resistant to immunotherapy and chemotherapy.
Rigel Pharmaceuticals (RIGL) Reports 33% RBC-TI Rate for R289 in MDS, Receives FDA Designations
Rigel Pharmaceuticals (RIGL) disclosed Phase 1b data showing 33% of MDS patients achieved transfusion independence with R289, which received FDA Orphan Drug and Fast Track designations.
Factual headline with ticker: Apimeds Pharmaceuticals US, Inc. (APUS) Two Directors Resign
Apimeds Pharmaceuticals US, Inc. (APUS) announced two directors resigned from its board on December 5, 2025, according to an SEC 8-K filing.